Twist Bioscience Grows Q3 Revenue 108%, but Losses Pile Up | Nasdaq

Among the trends sweeping Silicon Valley in recent years has been an appetite for propping up money-losing businesses in the name of returns. Of course, venture capitalists calculate returns much differently than individual investors, and it often goes unsaid that companies can be a start-up success and a commercial failure. 

Source: Twist Bioscience Grows Q3 Revenue 108%, but Losses Pile Up | Nasdaq